Details for Patent: 9,750,747

Which drugs does patent 9,750,747 protect, and when does it expire?

Patent 9,750,747 protects APTIOM and is included in one NDA.

This patent has five patent family members in four countries.

Summary for Patent: 9,750,747

Title:	Treatments involving eslicarbazepine acetate or eslicarbazepine
Abstract:	The invention provides a drug selected from eslicarbazepine acetate and eslicarbazepine, for use in treating or preventing a disorder selected from epilepsy, affective disorders, schizoaffective disorders, bipolar disorders, neuropathic pain and neuropathic pain related disorders, attention disorders, anxiety disorders, sensorimotor disorders, vestibular disorders, and fibromyalgia, in a patient suffering from or susceptible to absence seizures.
Inventor(s):	Soares Da Silva; Patricio Manuel Vieira Araujo (Sao Mamede do Coronado, PT)
Assignee:	BAIL-PORTELA & CA, S.A. (Sao Mamede do Coronado, PT)
Application Number:	14/240,847
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,750,747
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Delivery; Dosage form;

Drugs Protected by US Patent 9,750,747

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-001	Nov 8, 2013	AB	RX	Yes	No						TREATMENT OF PARTIAL-ONSET SEIZURES
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-001	Nov 8, 2013	AB	RX	Yes	No						TREATMENT OF PARTIAL-ONSET SEIZURES IN A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO ABSENCE SEIZURES
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-002	Nov 8, 2013	AB	RX	Yes	No						TREATMENT OF PARTIAL-ONSET SEIZURES IN A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO ABSENCE SEIZURES
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-002	Nov 8, 2013	AB	RX	Yes	No						TREATMENT OF PARTIAL-ONSET SEIZURES
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-003	Nov 8, 2013	AB	RX	Yes	No						TREATMENT OF PARTIAL-ONSET SEIZURES IN A PATIENT SUFFERING FROM OR SUSCEPTIBLE TO ABSENCE SEIZURES
Sumitomo Pharma Am	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-003	Nov 8, 2013	AB	RX	Yes	No						TREATMENT OF PARTIAL-ONSET SEIZURES

Foreign Priority and PCT Information for Patent: 9,750,747

PCT Information
PCT Filed	August 24, 2012	PCT Application Number:	PCT/PT2012/000031
PCT Publication Date:	March 07, 2013	PCT Publication Number:	WO2013/032351

International Family Members for US Patent 9,750,747

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2847235
European Patent Office	2747770
Russian Federation	2014111478
Russian Federation	2639120
World Intellectual Property Organization (WIPO)	2013032351